Amanote Research
Register
Sign In
PMS73 Visualizing Treatment Patterns of Veteran Patients With Rheumatoid Arthritis Who Initiated Tumor Necrosis Factor Therapy
Value in Health
- United Kingdom
doi 10.1016/j.jval.2012.08.1428
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
November 1, 2012
Authors
L. Wang
L. Xie
L. Li
A. Huang
H. Wang
O. Baser
Publisher
Elsevier BV
Related search
PMS9 Biologic Therapy Patterns and Associated Costs in Rheumatoid Arthritis Patients Who Initiated a Tumor Necrosis Factor Antagonist Over Two Years
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
PMS5 Data Visualization of Treatment Patterns of Medicare Psoriatic Arthritis Patients Who Initiate Tumor Necrosis Factor Therapy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Tumor Necrosis Factor Α Antagonists in the Treatment of the Patients With Rheumatoid Arthritis
Reumatologia
Rheumatology
Allergy
Immunology
Predictors of Treatment Initiation With Tumor Necrosis Factor-Α Inhibitors in Patients With Rheumatoid Arthritis
Journal of Managed Care Pharmacy
Tumor Necrosis Factor-Α Blockade Treatment Decreased CD154 (CD40-ligand) Expression in Rheumatoid Arthritis
PLoS ONE
Multidisciplinary
Erratum To: Anti-Tumor Necrosis Factor-Α Therapy and Changes of Flow-Mediated Vasodilatation in Psoriatic and Rheumatoid Arthritis Patients
Internal and Emergency Medicine
Internal Medicine
Emergency Medicine
PMS73 Epidemiology, Therapy Patterns and Functional Status of Patients With Juvenile Idiopatic Arthritis (JIA) in Russia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Unaffected Reaction Level in Tuberculin Skin Test by Long-Term Therapy With Tumor Necrosis Factor Inhibitors for Rheumatoid Arthritis
International Journal of Rheumatic Diseases
Rheumatology
Value of Antidrug Antibody Screening in Moderate-To-Severe Rheumatiod Arthritis Patients Who Failed Initial Tumor Necrosis Factor-Alpha Treatment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental